Aducanumab (BIIB037) is a human monoclonal antibody designed to selectively target aggregated forms of amyloid-beta (A??), a key pathological marker in Alzheimer?€?s disease (AD). Demonstrating effective penetration into brain tissue, Aducanumab is extensively utilized in the research of Alzheimer's disease mechanisms and potential therapies. This antibody is pivotal for studies focusing on the pathogenesis and treatment strategies of AD, providing essential insights into amyloid-beta dynamics and clearance in neural environments.
Aducanumab (BIIB037) is a human monoclonal antibody designed to selectively target aggregated forms of amyloid-beta (A??), a key pathological marker in Alzheimer?€?s disease (AD). Demonstrating effective penetration into brain tissue, Aducanumab is extensively utilized in the research of Alzheimer's disease mechanisms and potential therapies. This antibody is pivotal for studies focusing on the pathogenesis and treatment strategies of AD, providing essential insights into amyloid-beta dynamics and clearance in neural environments.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
